Managing Osteoporosis and Fragility Fractures An Italian perspective
These revised guidelines from the Italian Inter-Society Commission for Osteoporosis provide practical indications for the management of osteoporosis and for the diagnosis, prevention and treatment of fragility fractures. This is a shortened version of the original article.
Modern Medicine – Issue 6 2021
Absolute Fracture Risk What does it mean for your patient? – MM1604
Fracture prevention is the main goal of treatment for osteoporosis. Absolute fracture risk calculators have been developed that aim to better quantify fracture risk and may help to guide treatment decisions in certain situations. It may also help to clarify situations of low absolute fracture risk where treatment is not indicated.
Absolute fracture risk calculators incorporate clinical risk factors as well as bone mineral density into risk estimations. Commonly used fracture risk calculators are the WHO Fracture Risk Assessment Tool (FRAX) and the Garvan Fracture Risk Calculator (GFRC).
Modern Medicine – April 2016
Factors Influencing Vitamin D Status in Urban African Black and Asian-Indian Adults – MM1507
Vitamin D deficiency has been implicated in the aetiology of numerous infectious diseases and metabolic syndrome which are prevalent in the African and Asian-Indian populations of South Africa. There is limited data on 25-hydroxyvitamin D concentrations and limited comparative bone mineral density data on non- Caucasian population groups in South Africa.
Modern Medicine – July 2015
Why Use Parenteral Therapies for Osteoporosis? – MM1507
Treatment options for osteoporosis have dramatically changed over the past 15 years. The newer parenteral therapies, zoledronic acid and teriparatide, are effective treatment options with differing mechanisms of action. Here we review these new agents and compare their relative merits with existing oral medications for osteoporosis.
Modern Medicine – July 2015
Fracture Risk Reduction in Glucocorticoid-induced Osteoporosis – MM1411
Patients requiring more than three months of glucocorticoid therapy should be assessed with regards to their fracture risk. Calcium and vitamin D supplementation is recommended as preventive therapy for all patients taking glucocorticoids, and pharmacological intervention should also be considered.
Modern Medicine – November/December 2014
